Isaac Ciechanover

Corporate Officer/Principal at CYTOKINETICS, INCORPORATED

55 year

Health Technology

Consumer Services

Finance

Profile

Isaac E.
Ciechanover was the founder of Atara Biotherapeutics, Inc. (2012) and served as Chairman, President & Chief Executive Officer.
Current jobs include Director at Muna Therapeutics ApS, Partner at Polaris Growth Management LLC (2019), Partner at Qiming US Ventures Management, LLC (2022), and Chief Business Officer & Corporate Development at Cytokinetics, Inc. (2024).
Former jobs include President & Chief Executive Officer at Nina Biotherapeutics, Inc., President & Chief Executive Officer at Pinta Biotherapeutics, Inc., President & Chief Executive Officer at Santa Maria Biotherapeutics, Inc., Chairman at Auron Therapeutics, Inc., Executive Director-Business Development at Celgene Corp.
(2004-2010), Director at SQZ Biotechnologies Co., Principal at Amylin Pharmaceuticals, Inc., and Partner at Kleiner Perkins Caufield & Byers LLC.
Education includes undergraduate degree from Stanford University, graduate degree from the University of Cambridge, doctorate from Weill Cornell Medical College, and MBA from Harvard Business School.

Isaac Ciechanover active positions

Companies	Position	Start
CYTOKINETICS, INCORPORATED	Corporate Officer/Principal	01/06/2024
Qiming US Ventures Management, LLC Qiming US Ventures Management, LLC Investment ManagersFinance Qiming Venture Partners invests in companies located in the United States and Europe. The firm focuses on the healthcare sector. It participates in early stage capital transactions.	Private Equity Investor	01/06/2022
Muna Therapeutics ApS Muna Therapeutics ApS BiotechnologyHealth Technology Engages in discovering and developing of therapies that slow and stop devastating neurodegenerative, alzheimer’s & parkinson’s diseases	Director/Board Member	-
Polaris Growth Management LLC Polaris Growth Management LLC Investment ManagersFinance Polaris Partners invests primarily in companies in the consumer technology, digital media/entertainment, e-Commerce, network hardware, software and semiconductors sectors. They invest in seed, early-stage and high growth, middle-market companies. The firm's early-stage investments focus on information technology and life sciences companies. Within the information technology sector, Polaris looks for companies that are developing Internet and broadband infrastructure, enterprise software products, e-Commerce products/services, digital media/entertainment, consumer software, network hardware and network software. In the life sciences sector, the firm looks for companies that are developing medical devices, pharmaceuticals, genomics, proteomics, drug delivery, medical services and consumer products and services. Polaris' private equity efforts focus on high-growth, middle-market companies in industries including technology, healthcare, digital media, consumer products and services and business services. Polaris serves as the lead or co-lead investor in the vast majority of their portfolio companies. The firm participates in minority growth equity investments, recapitalizations with liquidity and LBOs.	Private Equity Investor	05/12/2019

All active positions of Isaac Ciechanover

Former positions of Isaac Ciechanover

Companies	Position	End
ATARA BIOTHERAPEUTICS, INC.	Chief Executive Officer	28/05/2019
CELGENE	Corporate Officer/Principal	01/03/2010
Amylin Pharmaceuticals, Inc. Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases	Corporate Officer/Principal	-
Nina Biotherapeutics, Inc. Nina Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer patients	Chief Executive Officer	-
Santa Maria Biotherapeutics, Inc. Santa Maria Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company	Chief Executive Officer	-

See the detail of Isaac Ciechanover's experience

Training of Isaac Ciechanover

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Isaac Ciechanover's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	17
Amylin Pharmaceuticals, Inc. Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases	Health Technology
Celgene Corp. Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs	Health Technology
Cytokinetics, Inc. Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products	Health Technology
SQZ Biotechnologies Co. SQZ Biotechnologies Co. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops cell therapies for patients with cancer, infectious diseases and serious conditions	Health Technology
Polaris Growth Management LLC Polaris Growth Management LLC Investment ManagersFinance Polaris Partners invests primarily in companies in the consumer technology, digital media/entertainment, e-Commerce, network hardware, software and semiconductors sectors. They invest in seed, early-stage and high growth, middle-market companies. The firm's early-stage investments focus on information technology and life sciences companies. Within the information technology sector, Polaris looks for companies that are developing Internet and broadband infrastructure, enterprise software products, e-Commerce products/services, digital media/entertainment, consumer software, network hardware and network software. In the life sciences sector, the firm looks for companies that are developing medical devices, pharmaceuticals, genomics, proteomics, drug delivery, medical services and consumer products and services. Polaris' private equity efforts focus on high-growth, middle-market companies in industries including technology, healthcare, digital media, consumer products and services and business services. Polaris serves as the lead or co-lead investor in the vast majority of their portfolio companies. The firm participates in minority growth equity investments, recapitalizations with liquidity and LBOs.	Finance
Stanford University Stanford University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Kleiner Perkins Caufield & Byers LLC Kleiner Perkins Caufield & Byers LLC Investment ManagersFinance Kleiner Perkins Caufield & Byers invests in companies located in the United States. The firm targets companies operating in consumer, enterprise, Fintech, hardtech and healthcare sectors. It provides financing for seed, early, and later stage capital requirements.	Finance
University of Cambridge University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Weill Cornell Medical College Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Harvard Business School Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Nina Biotherapeutics, Inc. Nina Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer patients	Health Technology
Pinta Biotherapeutics, Inc.
Santa Maria Biotherapeutics, Inc. Santa Maria Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company	Commercial Services
Atara Biotherapeutics, Inc. Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases	Health Technology
Qiming US Ventures Management, LLC Qiming US Ventures Management, LLC Investment ManagersFinance Qiming Venture Partners invests in companies located in the United States and Europe. The firm focuses on the healthcare sector. It participates in early stage capital transactions.	Finance
Auron Therapeutics, Inc. Auron Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which cure cancer by radically changing the paradigm of cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells	Commercial Services
Muna Therapeutics ApS Muna Therapeutics ApS BiotechnologyHealth Technology Engages in discovering and developing of therapies that slow and stop devastating neurodegenerative, alzheimer’s & parkinson’s diseases	Health Technology